L Szczepański

5.6k total citations · 3 hit papers
18 papers, 4.0k citations indexed

About

L Szczepański is a scholar working on Pharmacology, Rheumatology and Surgery. According to data from OpenAlex, L Szczepański has authored 18 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 6 papers in Rheumatology and 5 papers in Surgery. Recurrent topics in L Szczepański's work include Inflammatory mediators and NSAID effects (5 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Helicobacter pylori-related gastroenterology studies (4 papers). L Szczepański is often cited by papers focused on Inflammatory mediators and NSAID effects (5 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Helicobacter pylori-related gastroenterology studies (4 papers). L Szczepański collaborates with scholars based in Poland, United Kingdom and Sweden. L Szczepański's co-authors include Anna Filipowicz‐Sosnowska, Paul Emery, Randall M. Stevens, D. Close, Jonathan Edwards, Tim Shaw, Jacek Szechiński, Neville D. Yeomans, Christopher J. Hawkey and Donald G. Walker and has published in prestigious journals such as New England Journal of Medicine, The Lancet and The American Journal of Gastroenterology.

In The Last Decade

L Szczepański

17 papers receiving 3.9k citations

Hit Papers

Efficacy of B-Cell–Target... 1998 2026 2007 2016 2004 2006 1998 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis
    2004 1.9k citations Jonathan Edwards, L Szczepański et al. New England Journal of Medicine profile →
  2. The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: Results of a phase IIB randomized, double‐blind, placebo‐controlled, dose‐ranging trial
    2006 783 citations Paul Emery, Roy Fleischmann et al. Arthritis & Rheumatism profile →
  3. Omeprazole Compared with Misoprostol for Ulcers Associated with Nonsteroidal Antiinflammatory Drugs
    1998 653 citations Christopher J. Hawkey, L Szczepański et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L Szczepański Poland 11 1.7k 1.1k 922 820 801 18 4.0k
H Tannenbaum Canada 24 1.6k 1.0× 573 0.5× 415 0.5× 286 0.3× 393 0.5× 58 2.7k
Maria Greenwald United States 30 2.7k 1.6× 1.5k 1.4× 328 0.4× 226 0.3× 606 0.8× 76 5.1k
Elisa Gremese Italy 35 2.2k 1.3× 1.2k 1.2× 287 0.3× 102 0.1× 311 0.4× 243 4.2k
Leo B. A. Van De Putte Netherlands 18 1.4k 0.8× 615 0.6× 152 0.2× 312 0.4× 436 0.5× 34 2.6k
Andrew J.K. Östör United Kingdom 31 1.9k 1.2× 982 0.9× 580 0.6× 228 0.3× 184 0.2× 131 3.8k
Ann‐Kristin Ulfgren Sweden 21 1.5k 0.9× 1.4k 1.3× 222 0.2× 80 0.1× 374 0.5× 30 3.3k
John Sibley Canada 20 1.7k 1.0× 528 0.5× 305 0.3× 165 0.2× 225 0.3× 37 2.8k
Joung-Liang Lan Taiwan 17 1.9k 1.2× 1.3k 1.2× 189 0.2× 746 0.9× 718 0.9× 24 3.2k
Andreas Schwarting Germany 38 3.2k 1.9× 3.1k 2.9× 310 0.3× 66 0.1× 1.1k 1.4× 187 5.9k
Olivier Vittecoq France 36 2.0k 1.2× 776 0.7× 488 0.5× 60 0.1× 462 0.6× 165 3.5k

Countries citing papers authored by L Szczepański

Since Specialization
Citations

This map shows the geographic impact of L Szczepański's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Szczepański with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Szczepański more than expected).

Fields of papers citing papers by L Szczepański

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Szczepański. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Szczepański. The network helps show where L Szczepański may publish in the future.

Co-authorship network of co-authors of L Szczepański

This figure shows the co-authorship network connecting the top 25 collaborators of L Szczepański. A scholar is included among the top collaborators of L Szczepański based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Szczepański. L Szczepański is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Greenwald, Maria, L Szczepański, A C Kennedy, et al.. (2014). A 52-week, open-label study evaluating the safety and efficacy of tabalumab, an anti-B-cell-activating factor monoclonal antibody, for rheumatoid arthritis. Arthritis Research & Therapy. 16(4). 415–415. 13 indexed citations
2.
3.
Szczepański, L. (2011). Assessments of the non-surgical managements of osteoarthritis – a review. Postępy Nauk Medycznych.
4.
5.
6.
Szczepański, L. (2008). Soft tissue rheumatism in erderly. Polskie Archiwum Medycyny Wewnętrznej. 118(Suppl. 1). 54–58. 1 indexed citations
7.
Emery, Paul, Roy Fleischmann, Anna Filipowicz‐Sosnowska, et al.. (2006). The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: Results of a phase IIB randomized, double‐blind, placebo‐controlled, dose‐ranging trial. Arthritis & Rheumatism. 54(5). 1390–1400. 783 indexed citations breakdown →
8.
Scheiman, James M., Neville D. Yeomans, Nicholas J. Talley, et al.. (2006). Prevention of Ulcers by Esomeprazole in At-Risk Patients Using Non-Selective NSAIDs and COX-2 Inhibitors. The American Journal of Gastroenterology. 101(4). 701–710. 212 indexed citations
9.
Edwards, Jonathan, L Szczepański, Jacek Szechiński, et al.. (2004). Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis. New England Journal of Medicine. 350(25). 2572–2581. 1950 indexed citations breakdown →
10.
Pluta, Andrzej & L Szczepański. (2003). Reumatoidalne zapalenie stawów - zasady leczenia. Przewodnik Lekarza/Guide for GPs. 4(10). 22–28. 1 indexed citations
11.
Hawkey, Christopher J., L Szczepański, Donald G. Walker, et al.. (1999). Omeprazole Compared with Misoprostol for Ulcers Associated with Nonsteroidal Antiinflammatory Drugs. Survey of Anesthesiology. 43(3). 180–180. 64 indexed citations
12.
Hawkey, Christopher J., Zsolt Tulassay, L Szczepański, et al.. (1998). Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs. European Journal of Gastroenterology & Hepatology. 10(11). 978–978. 1 indexed citations
13.
Tulassay, Zsolt, et al.. (1998). Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. The Lancet. 352(9133). 1016–1021. 279 indexed citations
14.
Hawkey, Christopher J., L Szczepański, Donald G. Walker, et al.. (1998). Omeprazole Compared with Misoprostol for Ulcers Associated with Nonsteroidal Antiinflammatory Drugs. New England Journal of Medicine. 338(11). 727–734. 653 indexed citations breakdown →
15.
Szczepański, L, et al.. (1992). Deforming Arthropathy and Jaccoud's Syndrome in Patients with Systemic Lupus Erythematosus. Scandinavian Journal of Rheumatology. 21(6). 308–309. 13 indexed citations
16.
Woźniak, Kinga, et al.. (1969). [Plasma renin activity in arterial hypertension].. PubMed. 24. 143–52. 1 indexed citations
17.
Szczepański, L, et al.. (1966). [Metallic mercury in the lumen of the digestive tract].. PubMed. 19(14). 1113–5. 2 indexed citations
18.
Szczepański, L. (1966). [Electrolytes in the cells of skeletal muscles and in the myocardium in congestive heart failure].. PubMed. 21(26). 990–2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H Tannenbaum Breakdown of academic impact, for papers by Maria Greenwald Breakdown of academic impact, for papers by Elisa Gremese Breakdown of academic impact, for papers by Leo B. A. Van De Putte Breakdown of academic impact, for papers by Andrew J.K. Östör Breakdown of academic impact, for papers by Ann‐Kristin Ulfgren Breakdown of academic impact, for papers by John Sibley Breakdown of academic impact, for papers by Joung-Liang Lan Breakdown of academic impact, for papers by Andreas Schwarting Breakdown of academic impact, for papers by Olivier Vittecoq
Rankless by CCL
2026